Curaleaf (Biotechnology) Overview
- Year Founded
-
2010

- Status
-
Public
- Employees
-
5,519

- Stock Symbol
-
CURA

- Investments
-
36
- Share Price
-
$1.16
- (As of Friday Closing)
Curaleaf (Biotechnology) General Information
Description
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
Contact Information
Website
www.curaleaf.comCorporate Office
- 420 Lexington Avenue
- Suite 2035
- New York, NY 10170
- United States
Corporate Office
- 420 Lexington Avenue
- Suite 2035
- New York, NY 10170
- United States
Curaleaf (Biotechnology) Stock Performance
As of 11-Jul-2025, Curaleaf (Biotechnology)’s stock price is $1.16. Its current market cap is $913M with 757M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.16 | $0.99 | $0.71 - $4.45 | $913M | 757M | 303K | -$0.35 |
Curaleaf (Biotechnology) Financials Summary
As of 31-Mar-2025, Curaleaf (Biotechnology) has a trailing 12-month revenue of $1.31B.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 1,594,362 | 2,053,149 | 3,940,986 | 3,970,217 |
Revenue | 1,313,877 | 1,342,802 | 1,346,632 | 1,275,420 |
EBITDA | 221,665 | 232,366 | 187,907 | 167,859 |
Net Income | (228,207) | (215,423) | (281,197) | (370,099) |
Total Assets | 2,947,427 | 2,949,536 | 3,096,576 | 3,414,560 |
Total Debt | 846,597 | 853,823 | 883,547 | 928,729 |
Curaleaf (Biotechnology) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Curaleaf (Biotechnology) Comparisons
Industry
Financing
Details
Curaleaf (Biotechnology) Competitors (8)
One of Curaleaf (Biotechnology)’s 8 competitors is Cresco Labs, a Formerly VC-backed company based in Chicago, IL.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Cresco Labs | Formerly VC-backed | Chicago, IL | ||||
Verano Holdings | Corporation | Chicago, IL | ||||
Green Thumb Industries | Corporation | Chicago, IL | ||||
Acreage Holdings | Formerly PE-Backed | New York, NY | ||||
Canopy Growth | Formerly Accelerator/Incubator backed | Smiths Falls, Canada |
Curaleaf (Biotechnology) Patents
Curaleaf (Biotechnology) Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240285705-A1 | Aqueous extraction of cannabinoids | Pending | 28-Feb-2023 | ||
US-11629986-B2 | Squeeze doser with childproof cap | Active | 22-Jul-2021 | ||
US-20230026087-A1 | Squeeze doser with childproof cap | Active | 22-Jul-2021 | ||
US-20230392966-A1 | Squeeze doser with childproof cap | Pending | 22-Jul-2021 | ||
AU-2011276505-A1 | Cannabis drug delivery and monitoring system | Inactive | 28-Jun-2010 | A61M15/0028 |
Curaleaf (Biotechnology) Signals
Curaleaf (Biotechnology) Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Curaleaf (Biotechnology) Investments & Acquisitions (36)
Curaleaf (Biotechnology)’s most recent deal was a Merger/Acquisition with Brancaster Pharmaceuticals. The deal was made on 28-Jun-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Brancaster Pharmaceuticals | 28-Jun-2024 | Merger/Acquisition | Pharmaceuticals | ||
Northern Green Canada | 22-Apr-2024 | Merger/Acquisition | Pharmaceuticals | ||
Dark Heart Nursery | 17-Jan-2024 | Merger/Acquisition | Pharmaceuticals | ||
Half Moon Nursery | 17-Jan-2024 | Merger/Acquisition | Cultivation | ||
Clever Leaves (Cannabis Processing Facility in Setúbal, Portugal) | 05-Jul-2023 | Corporate Asset Purchase | Buildings and Property |
Curaleaf (Biotechnology) ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile

Pharmaceuticals
Industry
Rank
Percentile

Pharmaceuticals
Subindustry
Rank
Percentile

Curaleaf (Biotechnology) Exits (3)
Curaleaf (Biotechnology)’s most recent exit was on 04-Oct-2021 from Los Sueños Farms. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Los Sueños Farms | 04-Oct-2021 | Completed |
|
||
Alternative Therapies Group II | 03-Nov-2020 | Completed |
|
||
Elevate Takoma Dispensary | 10-Jan-2019 | Corporate Asset Purchase | Completed |
Curaleaf (Biotechnology) Affiliates
Subsidiaries (5)
Name | Industry | Location | Year Founded |
---|---|---|---|
Four 20 Pharma | Paderborn, Germany | 2018 | |
Grassroots Cannabis | Chicago, IL | 2014 | |
Northern Green Canada | Brampton, Canada | 2014 | |
The Spot 420 | Pueblo, CO | 2013 | |
Dark Heart Nursery | San Leandro, CA | 2007 |
Curaleaf (Biotechnology) FAQs
-
When was Curaleaf (Biotechnology) founded?
Curaleaf (Biotechnology) was founded in 2010.
-
Where is Curaleaf (Biotechnology) headquartered?
Curaleaf (Biotechnology) is headquartered in New York, NY.
-
What is the size of Curaleaf (Biotechnology)?
Curaleaf (Biotechnology) has 5,519 total employees.
-
What industry is Curaleaf (Biotechnology) in?
Curaleaf (Biotechnology)’s primary industry is Biotechnology.
-
Is Curaleaf (Biotechnology) a private or public company?
Curaleaf (Biotechnology) is a Public company.
-
What is Curaleaf (Biotechnology)’s stock symbol?
The ticker symbol for Curaleaf (Biotechnology) is CURA.
-
What is the current stock price of Curaleaf (Biotechnology)?
As of 11-Jul-2025 the stock price of Curaleaf (Biotechnology) is $1.16.
-
What is the current market cap of Curaleaf (Biotechnology)?
The current market capitalization of Curaleaf (Biotechnology) is $913M.
-
What is Curaleaf (Biotechnology)’s current revenue?
The trailing twelve month revenue for Curaleaf (Biotechnology) is $1.31B.
-
Who are Curaleaf (Biotechnology)’s competitors?
Cresco Labs, Verano Holdings, Green Thumb Industries, Acreage Holdings, and Canopy Growth are some of the 8 competitors of Curaleaf (Biotechnology).
-
What is Curaleaf (Biotechnology)’s annual earnings per share (EPS)?
Curaleaf (Biotechnology)’s EPS for 12 months was -$0.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »